LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Income Taxes Receivable
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Income Taxes Receivable of $280.00 thousand for the 9-month period ending 2016-02-28, per its 10-Q filed 2016-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2016-03-30
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes receivable for the quarter ending 2015-08-30 was -$92.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes receivable for the quarter ending 2015-05-31 was -$1.31M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes receivable for the quarter ending 2015-03-01 was $880.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes receivable for the quarter ending 2014-11-30 was -$944.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes receivable for fiscal 2015 was -$2.31M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes receivable for fiscal 2014 was -$5.03M, a 233.86% decline from fiscal 2013.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes receivable for fiscal 2013 was $3.75M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes receivable for fiscal 2012 was -$4.58M.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 3 month as first filed | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 6 month as first filed | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 9 month as first filed | Increase (Decrease) in Income Taxes Receivable 12 month | Increase (Decrease) in Income Taxes Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-02-28 | $280.00K 10-Q · filed 2016-03-30 | |||||||
| 2015-08-30 | -$92.00K 10-Q · filed 2015-10-01 | -$1.41M derived: sum of 2 quarters · filed 2015-10-01 | -$525.00K derived: sum of 3 quarters · filed 2015-10-01 | -$1.47M derived: sum of 4 quarters · filed 2015-10-01 | ||||
| 2015-05-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | -$433.00K derived: sum of 2 quarters · filed 2015-07-31 | -$1.38M derived: sum of 3 quarters · filed 2015-07-31 | -$2.31M 10-K · filed 2015-07-31 | ||||
| 2015-03-01 | $880.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$64.00K derived: sum of 2 quarters · filed 2015-04-02 | -$1.00M 10-Q · filed 2016-03-30 | -$3.23M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-11-30 | -$944.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$1.88M 10-Q · filed 2015-01-09 | -$4.11M derived: sum of 3 quarters · filed 2015-07-31 | -$6.64M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-08-31 | -$936.00K 10-Q · filed 2015-10-01 | -$3.16M derived: sum of 2 quarters · filed 2015-07-31 | -$5.70M derived: sum of 3 quarters · filed 2015-07-31 | -$5.80M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-05-25 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | -$4.76M derived: sum of 2 quarters · filed 2015-07-31 | -$4.86M derived: sum of 3 quarters · filed 2015-07-31 | -$5.03M 10-K · filed 2015-07-31 | ||||
| 2014-02-23 | -$2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$2.64M derived: sum of 2 quarters · filed 2015-04-02 | -$2.80M 10-Q · filed 2015-04-02 | $3.75M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-11-24 | -$101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$262.00K 10-Q · filed 2015-01-09 | $6.28M derived: sum of 3 quarters · filed 2015-07-31 | $5.33M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-08-25 | -$161.00K 10-Q · filed 2014-10-08 | $6.38M derived: sum of 2 quarters · filed 2015-07-31 | $5.43M derived: sum of 3 quarters · filed 2015-07-31 | $3.83M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-05-26 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $5.59M derived: sum of 2 quarters · filed 2015-07-31 | $3.99M derived: sum of 3 quarters · filed 2015-07-31 | $3.75M 10-K · filed 2015-07-31 | ||||
| 2013-02-24 | -$950.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | -$2.55M derived: sum of 2 quarters · filed 2014-03-28 | -$2.79M 10-Q · filed 2014-03-28 | -$1.50M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-11-25 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | -$1.84M 10-Q · filed 2014-01-03 | -$551.00K derived: sum of 3 quarters · filed 2014-08-01 | -$2.87M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-08-26 | -$236.00K 10-Q · filed 2013-09-26 | $236.00K 10-Q · filed 2012-10-03 | $1.05M derived: sum of 2 quarters · filed 2014-08-01 | -$1.26M derived: sum of 3 quarters · filed 2014-08-01 | -$3.49M derived: sum of 4 quarters · filed 2014-08-01 | |||
| 2012-05-27 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | -$1.03M derived: sum of 2 quarters · filed 2014-08-01 | -$3.25M derived: sum of 3 quarters · filed 2014-08-01 | -$4.58M 10-K · filed 2014-08-01 | $4.58M 10-K · filed 2012-08-08 | |||
| 2012-02-26 | -$2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | -$4.54M derived: sum of 2 quarters · filed 2013-04-04 | -$5.87M 10-Q · filed 2013-04-04 | $5.87M 10-Q · filed 2012-03-28 | -$9.12M derived: sum of 4 quarters · filed 2013-08-07 | |||
| 2011-11-27 | -$2.23M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | -$3.55M 10-Q · filed 2013-01-04 | $3.55M 10-Q · filed 2012-01-05 | -$6.80M derived: sum of 3 quarters · filed 2013-08-07 | ||||
| 2011-08-28 | -$1.33M 10-Q/A · filed 2013-01-02 | $1.33M 10-Q · filed 2011-10-05 | -$4.57M derived: sum of 2 quarters · filed 2013-08-07 | |||||
| 2011-05-29 | -$3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$878.00K 10-K · filed 2013-08-07 | $878.00K 10-K · filed 2012-08-08 | |||||
| 2011-02-27 | $2.37M 10-Q · filed 2012-03-28 | |||||||
| 2010-11-28 | $1.68M 10-Q · filed 2012-01-05 | |||||||
| 2010-08-29 | $874.00K 10-Q · filed 2011-10-05 | |||||||
| 2010-05-30 | -$764.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |